semaglutide studies 2024 Effects of Once-Weekly on Kidney Disease Outcomes by KDIGO Risk Category in the SUSTAIN 6 Trial Semaglutide in patients with overweight

Its important to not that Semaglutide GLP-1 injections are not meant to be a quick-fix solution for dropping excess weight

The combination of altered eating patterns, potential fluid loss, and metabolic adjustments may create conditions conducive to headache development

For context on expected results, the retatrutide results timeline covers what to expect at each stage

A new finding, not commonly reported in the subcutaneous semaglutide clinical trial program, was dysesthesia

These include: intense abdominal pain, which could be a sign of pancreatitis, gallbladder disease, gallstones, or gallbladder inflammation changes in your vision, which could be caused by diabetic retinopathy extreme hypoglycemia (low blood sugar) severe allergic reaction, such as your throat swelling (anaphylaxis) a lump in your throat or difficulty swallowing, which could be a sign of thyroid cancer Disclaimer: While Healthline strives for factual, comprehensive, and current information, this article is not a substitute for a licensed healthcare professionals expertise